Saturn-1 patients' collarettes at baseline and post treatment
Saturn-1 patients' collarettes at baseline (Day 0, Grade 4) and post treatment (Day 43, Grade 0, left) and (Day 43, Grade 1, right). Images demonstrate results which we believe are representative of favorable treatment with TP-03 for patients participating in the Saturn-1 trial. Other patients may experience different or less favorable results.
Format
JPEG
Source
Tarsus Pharmaceuticals, Inc